Search

everythinglearnresearchcommunity

for

Search:↓

Different genes cause Female Pattern Hair Loss compared to male hair loss, and treatments vary, but more research is needed to understand it fully.

Using both minoxidil and finasteride together is more effective for male hair loss than using either one alone.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Understanding genes and hormones is crucial for managing male puberty and sex development disorders.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

17β-Estradiol slows wound healing in male mice through estrogen receptor-α.

The roadmap calls for better research and funding to improve PCOS diagnosis, treatment, and health outcomes.

BMI is a simple, cost-effective tool for screening obesity and related diseases.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Genetic variants can affect valproic acid's effectiveness, side effects, and levels in epilepsy treatment.

Compound 4 is a promising treatment for hair loss with low toxicity.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Analyzing follicular fluid can help predict and improve outcomes for women with PCOS undergoing fertility treatments.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Probiotics and synbiotics might help manage hirsutism by improving insulin resistance.

Androgens increase cervical cancer risk and affect its development.

Improving human hair follicle models is crucial for better hair loss treatments.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

24-Hydroxycholesterol reduces DHT formation in brain cancer cells, linking cholesterol and hormone metabolism.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.